Clinical Characteristics of Elderly Patients With PPI-Refractory NERD From the G-PRIDE Study Who Responded to Rikkunshito

被引：0

作者：

Umegaki, Eiji

Kato, Mototsugu

Takeda, Hiroshi

Tominaga, Kazunari

Kusunoki, Hiroaki

Furuta, Kenji

Sakurai, Kouichi

Odaka, Takeo

Kinoshita, Yoshikazu

Haruma, Ken

Takahashi, Shin'ichi

Higuchi, Kazuhide

Kusano, Motoyasu

Fujimoto, Kazuma

Arakawa, Tetsuo

机构：

来源：

GASTROENTEROLOGY | 2014年 / 146卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Sa1093

引用

页码：S198 / S198

页数：1

共 37 条

[31] Clinical Characteristics and Long-Term Prognosis of Elderly Valvular Heart Disease Patients with Diabetes Mellitus: Five-Year Experience from a Single-Center Study of Southern China [J].

Liang, Yuan-Feng ;

Song, Feier ;

Liu, Huixia ;

Liu, Jian ;

Zhang, Yu-Yuan ;

Lin, Wei-Dong ;

Liao, Hong-Tao ;

Guo, Hui-Ming ;

Tse, Gary ;

Liu, Fang-Zhou ;

Lin, Zhanyi .

CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021

[32] Comparison of clinical characteristics between patients with coronavirus disease 2019 (COVID-19) who retested RT-PCR positive versus negative: a retrospective study of data from Nanjing [J].

Liu, Yuan ;

Ding, Ning ;

Zhou, Shixiang ;

Chen, Chen ;

Huang, Shan ;

Lv, Yanling ;

Jiao, Damin ;

Zheng, Yishan ;

Hu, Zhiliang ;

Xu, Chuanjun ;

Chen, Wei ;

Dai, Hui ;

Sun, Wenkui ;

Cheng, Cong ;

Lv, Ru ;

Cheng, Jian ;

Ye, Zi ;

Li, Zhengjie ;

Yi, Yongxiang ;

Wei, Hongxia .

JOURNAL OF THORACIC DISEASE, 2020, 12 (11) :6435-6445

[33] Real-world safety and effectiveness outcomes of Venetoclax monotherapy in patients with relapsed/refractory CLL, who did not match key inclusion criteria of pivotal clinical trials - Results from the non-interventional study VeRVe [J].

Schwaner, I ;

Hebart, H. ;

Losem, C. ;

Wolff, T. ;

Schmidt, B. ;

Rossi, D. ;

Hettinger, J. ;

Huelsenbeck, J. ;

Noesslinger, T. .

ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 :156-156

[34] Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202) [J].

Wang, Xiang ;

Zhong, Diansheng ;

Zhang, Junping ;

Du, Nan ;

Ren, Yuchuan ;

Gao, Jinghua ;

Liu, Likun ;

Yu, Junyan ;

Li, Xiaomei ;

Ma, Liwen ;

Zang, Aimin ;

Yang, Mudan ;

Zhang, Yan ;

Guo, Jun ;

Liu, Zheng ;

Fu, Zhanzhao ;

Jia, Junmei ;

Diao, Jianfeng ;

Fan, Zaiwen ;

Song, Xiang ;

Li, Guozhong ;

Wang, Huaqing ;

Bai, Chunmei ;

Guan, Mei ;

Ren, Xiubao ;

Zhang, Ruixing .

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (04) :1679-1689

[35] Biomarker Correlates and Clinical Activity of Cevostamab in Patients (pts) with Triple-Class Refractory Multiple Myeloma (MM) Who Have Received ≥1 Prior B-Cell Maturation Antigen (BCMA)-Targeted Bispecific Antibody (BsAb): Results from the Phase I/II CAMMA 2 Study [J].

Delforge, Michel ;

Richter, Joshua ;

Cohen, Yael C. ;

Corradini, Paolo ;

Sborov, Douglas W. ;

Lesokhin, Alexander M. ;

Berdeja, Jesus G. ;

Gatt, Moshe E. ;

Paris, Laura ;

Dachs, Laura Rosinol ;

Quach, Hang ;

Kanwar, Manisha ;

Catalani, Olivier ;

Sewpaul, Paresh ;

Wassner-Fritsch, Elisabeth ;

Mishra, Ameet ;

Trunzer, Kerstin ;

Kumar, Shaji .

BLOOD, 2024, 144 :4733-4734

[36] Prevalence and clinical characteristics of metastatic synovial sarcoma (mSS) patients with tumours expressing NY-ESO-1 antigen (NY plus ) and who are HLA-A*02:01,*02:05 or*02:06 allele positive (HLA plus ): Cohort study from the French sarcoma group [J].

Dufresne, A. ;

Meurgey, A. ;

Chabaud, S. ;

Bollard, J. ;

Jean-Denis, M. ;

Tonon, L. ;

Gadot, N. ;

Le Neve, C. ;

Blay, J-Y. ;

Woessner, M. ;

Klohe, E. ;

Thayaparan, T. ;

Blouch, K. ;

Eleftheriadou, I. ;

Nathenson, M. J. ;

Pokras, S. .

ANNALS OF ONCOLOGY, 2022, 33 (07) :S1234-S1234

[37] Clinical Activity of BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma (MM): First Results from a Phase 1, Multicenter, Open-Label Study [J].

Bal, Susan ;

Kocoglu, M. Hakan ;

Nadeem, Omar ;

Htut, Myo ;

Gregory, Tara ;

Anderson, Larry D., Jr. ;

Costa, Luciano J. ;

Buchholz, Tonia J. ;

Ziyad, Safiyyah ;

Li, Meng ;

Chen, Yanping ;

Kaeding, Allison J. ;

Burgess, Michael R. ;

Hege, Kristen ;

Berdeja, Jesus .

BLOOD, 2022, 140

← 1 2 3 4 →